Related Experiment Video
Updated: Mar 27, 2026

09:34
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
2.4K
[Smoking and adherence to anti-tuberculosis treatment].
M Underner1, J Perriot2, G Peiffer3
1Service de pneumologie, centre de lutte antituberculeuse (CLAT 86), CHU La Milétrie, 86021 Poitiers, France.
Revue Des Maladies Respiratoires
|January 19, 2016
Summary
Active smoking is linked to poor adherence to tuberculosis treatment. Smoking cessation support is crucial for tuberculosis patients to improve treatment outcomes and control the epidemic.
Area of Science:
- Public Health
- Infectious Diseases
- Addiction Medicine
Background:
- Smoking and tuberculosis (TB) are significant global health challenges.
- Tobacco smoke exacerbates Mycobacterium tuberculosis infection and pulmonary TB severity.
- Smokers face higher risks of TB relapse and reduced adherence to anti-TB treatment.
Purpose of the Study:
- To review the international literature on the association between active smoking and adherence to anti-tuberculosis treatment.
- To highlight the impact of smoking on treatment compliance in TB patients.
Main Methods:
- A general review of 17 studies was conducted.
- The literature search focused on the link between active smoking and adherence to anti-TB therapy.
Main Results:
- A positive association was found between active smoking and non-adherence to anti-tuberculosis treatment.
- Smokers demonstrate lower adherence rates compared to non-smokers.
Conclusions:
- Active smoking negatively impacts adherence to anti-tuberculosis treatment.
- Systematic smoking cessation interventions are essential for TB patients to improve treatment success and control the TB epidemic, particularly in developing countries.
Keywords:
Anti-tuberculosis treatmentAntituberculeuxObservance thérapeutiqueSevrage tabagiqueSmokingSmoking cessationTabagismeTreatment adherenceTuberculoseTuberculosisMore Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
768
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
768
Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis IV
632
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
632
Other Pulmonary Disorders
2.0K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K
Pulmonary Tuberculosis II
2.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K
Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K

